The MS HLS experience is enhanced by the integration of notable figures in the realm of Health Policy, Strategy, and Healthcare Reform.
Distinguished guest speakers of the program include/have included:
Daniel Aaron, Associate Professor of Law, University of Utah
Dr. Daniel G. Aaron is an Associate Professor of Law at the S.J. Quinney College of Law, University of Utah. He received his JD from Harvard Law School and his MD from the Boston University Chobanian & Avedisian School of Medicine.
Professor Aaron’s research examines how the law shapes life and death in the United States and the legal and social trends that explain the fall in American life expectancy. This involves studying breakdowns in regulatory and legal systems that contribute to American mortality and wrestling with how to repair them. To this end, he has published articles on the intersection of food and drug law, administrative law, tort and multidistrict litigation, tobacco, racial inequity, corporate power, and regulatory capture.
Prior to joining the law school, Professor Aaron clerked for the U.S. Court of Appeals for the Sixth Circuit with Judge John K. Bush. Before that, he served as Assistant Chief Counsel at the U.S. Food and Drug Administration. During that time, he was also a Heyman Fellow at Harvard Law School, and he is a member of the Justice Initiative, a collaboration between Harvard Law School and Howard University School of Law aimed at providing law students a community space to discuss the intersection of race, justice, and the law.
Professor Aaron teaches primarily in the areas of Tort Law and Health Law.
CloseZach Baron, Director of Health Policy
Zachary Baron is a director of the Health Policy and the Law Initiative at the O’Neill Institute for National and Global Health Law and an adjunct professor at Georgetown Law.
CloseNick Bath, Partner, Manatt Health
A veteran health policy and legislative professional, Nicholas (Nick) Bath has nearly two decades of experience methodically advancing transformative health care policy from proposal into law.
Nick has substantive understanding of myriad health care regulations and statutes coupled with a deep familiarity with the policymaking process necessary to design effective strategies. Drawing on this experience, Nick helps clients best position themselves for success within the quickly evolving and increasingly complex health care landscape. His practice focuses particularly on commercial market health insurance coverage and reimbursement, federal public health agencies—including the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control (CDC)—and preparedness.
Prior to joining Manatt, Nick was Health Policy Director of the U.S. Senate Committee on Health, Education, Labor and Pensions for eight years, where he helped develop, draft, negotiate and enact groundbreaking health care laws. Among his accomplishments are multiple FDA regulatory reforms, including two laws extending, funding and amending the entirety of FDA’s human medical product review programs. He also worked on major pandemic response and reform bills, laws expanding and fundamentally altering private insurance coverage, and commercial health insurance reimbursement changes.
CloseAnna Berent, Senior Director, MCIC Vermont, LLC
For almost 15 years Anna Berent has been entrenched in the field of medical malpractice liability analysis. She’s currently working as a Senior Director of Claims at MCIC Vermont, the largest risk retention group in the country that insures several major hospital systems in the Northeast. Anna’s current role entails leading a team in managing high exposure matters. Having started her career as a litigator, Anna has worked for a premier specialty lines insurance carrier and a medical malpractice third-party administrator. She is a contributor to the ED Management, a monthly Relias publication.
Anna is a graduate of Northeastern University School of Law, and holds an MBA/MS in Healthcare Leadership from Cornell University where she also received her undergraduate degree.
CloseAlexandra “Alexa” Berk King, PhD, Chief Scientific Officer, Real-World Evidence, Clinical Trial Services, CVS Health
Alexa Berk is Chief Scientific Officer for RWE at CVS Health Clinical Trial Services, where she provides scientific leadership and oversees Data Science for CVS Health CTS. Most recently, Alexa was Medical Affairs Director for Digital Health and Data at Invitae, a leading medical genetics company. Alexa has a history of over 20 years in the health research space including roles at Memorial Sloan Kettering Cancer Center, Novartis Oncology, and top consulting and startup companies focused on RWE. Alexa is a frequent speaker and published author on the topic of high quality real world data and best practices in patient centered research methods, particularly in oncology and rare disease.
CloseNiall Brennan, Senior Advisor for Data Strategy to the CDC Director
Niall Brennan is the Senior Advisor for Data Strategy to the CDC Director. In this role, he provides guidance to the CDC Director on the multi-billion dollar CDC Data Modernization Initiative (DMI), as well as working directly with CDC Centers and Offices to accelerate implementation of the DMI.
CloseBlair Cantfil, Partner, Manatt Health
Blair Cantfil helps clients develop strategies to navigate emerging health care policy and enforcement trends. She provides counsel to a broad-based group of companies in the health care industry, assisting these clients in matters related to federal health care program access and reimbursement, fraud and abuse, compliance, and internal and governmental investigations.
Blair is a creative problem solver who views her clients as business partners. She develops legal and policy solutions that enable her clients to operate effectively in an increasingly complex regulatory environment. Blair’s work spans both Congress and federal agencies. She has experience advocating client issues before all congressional committees with jurisdiction over health care as well as implementing new laws through the rulemaking process. Blair has extensive experience working with trade associations and coalitions.
She has particular experience in health care policy and regulation affecting cancer care, large health care providers including academic medical centers and hospital systems and nonprofit organizations. Blair also helps her clients navigate payment and delivery system reform, patient assistance programs, and applications of federal fraud and abuse laws to the hospital and pharmaceutical industries.
Prior to joining Manatt, Blair was counsel at an international law firm. Previously, she clerked with the U.S. Department of Health & Human Services and the U.S. Court of Federal Claims. Blair has also consulted with the World Health Organization and worked with the U.S. Department of Agriculture Food and Nutrition Services. She obtained a Honduran nursing degree during her Peace Corps service.
CloseCarlos Infante de Castro, Former Chief Executive, SulAmérica
Carlos I. Castro has served for over 20 years on Board of Directors of Brazilian large, medium, small public, private, and family-owned companies (SulAmérica, Kepler-Weber, Artecola, Caixacap, Brasilcap), as well as on Board Committees (Corporate, Investment, Financial, Auditing). He served as CEO for twelve years, seven in the financial (savings bonds) and five in the industrial (telecom equipment) industries, as well as in C-Suite positions (CFO, Corporate VP, Pension VP). He led IPOs, strategy, and turnarounds processes. For 20 years he served as a member of the four-member committee in charge of all strategic decisions of the SulAmérica Group. He has extensive exposure to family-owned processes.
For five years, Mr. Castro managed his own consultancy practice, focused on top management issues. He holds a CCA+ certification from IBGC (Brazilian Institute of Corporate Governance), where he is currently a full member of the Healthcare Governance Commission, with a term ending in 2028.
Among many other M&A transactions fully conducted by him, he led the Sul América negotiating teams leading to the business combination with Rede D’Or, creating a joint company valued at over US$ 18 billion (2022), the sale of SulAmérica’s auto insurance business to Allianz (2019), the sale of SulAmérica’s large risk portfolio to AXA, and the JVs with ING (2002) and Aetna (1997). He served on the Ethics Committee of CNSeg for six years, and for seven years as VP of the Brazilian Association of Savings Bonds Companies (Fenacap). For seven years, he acted as an interviewer for the Stanford Graduate School of Business and is currently an interviewer for the Stanford University undergraduate applicants in Rio.
Mr. Castro holds an Electrical Engineering degree from the Catholic University of Rio de Janeiro, Brazil. He is also an MBA and a Master of Sciences in Industrial Engineering (straight “A” student), both degrees from Stanford. He was a Harvard University Research Scholar for the full year of 2019, becoming a Harvard Fellow in the Advanced Leadership Initiative. He has taken several courses in areas such as Sustainability (MIT), Corporate Governance (Stanford), AI (Stanford), Machine Learning and Advanced Analytics in Healthcare (Stanford), Leadership & Innovation (MIT), Electric Vehicles (Stanford), Educational Innovation and Social Entrepreneurship (Harvard), Emerging Technologies in Education (Harvard), and the executive program of Singularity University. Mr. Castro is also experienced in digitalization and ESG processes from a Board of Directors perspective.
CloseSteve Cha, Former Counselor to Secretary at U.S. Department of Health and Human Services
Dr. Cha was the former Counselor to the Secretary of Health and Human Services, with a portfolio that includes the Food and Drug Administration, and coordination of COVID-19 response across the Department. Prior to joining HHS, he served as the Chief Medical Officer for United Healthcare Community & State, responsible for about 6 million Medicaid and CHIP members in 29 states and the District of Columbia. Before that time, Dr. Cha served in federal government for about 12 years prior to that, leading state innovations at the Center on Medicare and Medicaid Innovation and also served as first Chief Medical Officer for the Center on Medicaid and CHIP Services, both within the Centers for Medicare & Medicaid Services. He also served in the U.S. House of Representatives under Chairman Henry A. Waxman, as senior professional staff for the Committee on Energy and Commerce and the Committee on Oversight and Government Reform. Until the COVID-19 pandemic, Dr. Cha served as a part time primary care physician in a homeless shelter in Washington, DC for over a decade.
CloseEllie Dehoney, Senior Vice President of Policy and Advocacy, Research!America
Ellie Dehoney is the Senior Vice President of policy and advocacy at the nonpartisan, nonprofit advocacy alliance, Research!America. Previously, she served as legislative director for Sen. Sherrod Brown (D-OH), and as health legislative assistant and legislative director for Brown in the House of Representatives. Ellie’s background also includes serving as a health legislative assistant for former Senate Minority Leader Tom Daschle (D-SD), as a special assistant in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) within the Department of Health and Human Services, and in nonprofit and private sector roles focused on health care financing and delivery.
Ellie currently serves on the Advisory Board of the George Mason University College of Health and Human Services, the AcademyHealth Committee on Advocacy and Public Policy, and the Nominating Committee of the National Health Council.
Ellie received a Bachelor’s degree in Economics and English from the College of William & Mary and a Master’s degree in Public Health from UNC Chapel Hill.
CloseJennifer Dexter, Vice President, Policy, National Health Council
Jennifer Dexter is the Vice President of Policy with the National Health Council, and she helps the NHC’s member organizations to establish policy positions which seek to improve the lives of people with chronic diseases and disabilities.
Dexter is also one of the NHC’s most visible public faces, often making her way over to Capitol Hill itself where she further advocates for critical health care reform policies with key lawmakers and representatives from the executive branch.
Prior to joining the NHC in September 2019, Dexter spent two and a half years as a product director at Anthem, Inc. helping them develop and shape Medicaid solutions that supported people with disabilities, older adults, and children in foster care. Prior to that, Dexter led Easterseals’ efforts with Congress annually to assure funding for all federal programs serving people with disabilities and older adults, including Easterseals’ federal programs.
Dexter worked with Congress to create and strengthen public policy affecting people with disabilities and older adults, particularly in long-term services and supports. From her time at Easterseals’ to her current work with the NHC, the continued protection and enhancement of legislation such as the Affordable Care Act has been a top priority for Dexter and her team. During her down time, Dexter is kept happily occupied as the mother of an incredibly busy teenage son, as they bond over their shared love of basketball. Dexter earned her BA in political science from Washington University in St. Louis.
CloseHamza Drabu, Partner and Head of Health, DAC Beachcroft LLP
Hamza specializes in commercial law, regulatory and governance matters. Hamza has advised on a number of projects with an international focus, including advising clients on inward investment projects into the UK, as well as leading on multi-jurisdictional projects alongside an international team of lawyers.
He has over 12 years’ experience advising clients in the health and social care sector. His key clients include medtech and digital health companies, NHS commissioners and providers, independent operators of health and social care, at-scale providers of primary care services and voluntary sector organizations. He has advised on a broad range of matters, including major strategic procurements, public/private sector collaborations, mergers and acquisitions, regulatory due diligence and highly regulated commercial contracts in the health and social care sector.
Hamza’s experience in advising health and social care sector clients means that he is expert in understanding the regulatory framework that they operate within; his commercial advice is provided in that context.
Relevant experience includes advising:
A range of new market entrants seeking to establish digital health solutions in the NHS on commercial, regulatory and strategic matters.
A national commissioner on the commercial and procurement aspects in a competitive process for a major strategic procurement process to roll out medical technology across the country, focussed on better access to cancer diagnostics.
A medtech company on its contractual arrangements for collaboration with NHS Trusts/FTs for the provision of capital equipment.
Various integrated care systems in the NHS seeking to integrate commissioning governance, and allow for a more co-ordinated provision of health and social care services.
Hamza is recognised by the Legal 500 as a “Next Generation Partner”, and is described as “The ‘quick thinking’ Hamza Drabu who ‘understands clients’ needs and designs creative solutions to complex problems’.”
Hamza featured in the 2,000 Days Project, setting out practical ways to overcome legal barriers in order to help the NHS reform health and social care provision. The 2,000 Days Project was reported on in The Guardian.
CloseEric Dworkin, Payer Strategy, White Plains Hospital; Former Executive Director, Physician-Hospital Organization, Hospital for Special Surgery
Eric brings 30+ years of healthcare industry and consulting experience. Eric serves as the Senior Director of Revenue Cycle at White Plains Hospital where he works closely with payors and providers to develop and continuously refine the process to maximize revenue in an efficient and compliant manner. Prior to joining White Plains Hospital, he was the Executive Director of the Hospital for Special Surgery Physician-Hospital Organization (PHO) for 18+ years where his role included the negotiation, implementation, and management of payor contracts, including securing favorable terms and enhanced reimbursement for existing and advanced services. Eric earned his BA from the University of Wisconsin and MPA in Health Policy and Management from the New York University Robert F. Wagner Graduate School of Public Service.
CloseJack Ebeler, Principal at Health Policy Alternatives
Jack Ebeler is a principal at Health Policy Alternatives, a Washington, DC-based consulting firm. In 2009 and 2010, he worked on Capitol Hill on the development of health reform legislation, serving on the staff of the U.S. House of Representatives Committee on Energy and Commerce. Before joining the House Committee staff for the health reform debate, he was an independent consultant and served as a member and then vice-chair of the Medicare Payment Advisory Commission (MedPAC) as it was advancing substantial Medicare payment and delivery reforms. Prior to that, he was president and CEO of the Alliance of Community Health Plans and senior vice president and the initial director of the Health Care Group at the Robert Wood Johnson Foundation. In 1995 and 1996 he served at HHS as deputy assistant secretary for planning and evaluation/health and then as acting assistant secretary for planning and evaluation.
CloseSarah Egge, Principal and Founding Partner, SplitOak Strategies
Sarah launched her career in the late 1990s as a Legislative Assistant and Policy Analyst to former Finance Committee member Senator Bob Kerrey (D-NE), advising him on tax, health care, Social Security, budget and appropriations matters.
For nearly a dozen years, Sarah served as the lead health care and entitlements analyst for the Democratic Staff of the Senate Budget Committee under Chairman Kent Conrad (D-ND). She has extensive expertise in the budget, reconciliation and appropriations processes, and was deeply involved with the development and advancement of key legislation, including the Affordable Care Act, the Budget Control Act, the Statutory Pay-As-You-Go Act, and the Deficit Reduction Act.
Sarah was a key advisor to Chairman Conrad during his participation with the National Commission on Fiscal Responsibility and Reform (aka, “Bowles-Simpson Commission”). She was selected by Co-Chairman Senator Patty Murray (D-WA) to serve as Deputy Staff Director of the Joint Select Committee on Deficit Reduction (aka, the “Supercommittee”), where she helped Committee members navigate complex policy and budgetary tradeoffs of a major deficit reduction package.
Following nearly 15 years in the U.S. Senate, Sarah joined the team at Washington Council EY, where she worked with pharmaceutical and device manufacturers, large national employers, health insurers, health insurance agents and brokers, health care providers, and think tanks to shape national health policy.
Sarah received a B.A. in History and Public Affairs from the University of Denver and a Masters Degree in Public Policy from the Kennedy School of Government at Harvard.
Close Sabina Ewing, SVP & CIO, Abbott
Sabina is Senior Vice President, Business and Technology Services and Chief Information Officer at Abbott. She was promoted to this role in February 2024 after serving as CIO and Vice President, Business & Technology Services. In her current role, Sabina provides executive leadership on technology strategy, policy, and capabilities across the Abbott enterprise.
Sabina joined Abbott in November of 2020 after serving in multiple IT roles at Pfizer, most recently as a Global Head of Upjohn Business Technology, where she was based in Shanghai, China. Prior to joining Pfizer, Sabina held management roles at Arthur Andersen Business Consulting, BearingPoint, and American Express. She is also a former New York City Teaching Fellow where she served as a fifth-grade teacher in the South Bronx.
A diversity and inclusion advocate, Sabina has been actively involved in many aspects of D&I to help build a more diverse workforce and prepare organizations for the years to come, including with organizations such as Advancing Minorities’ Interest in Engineering, which helps prepare underrepresented students for careers in engineering and computer science.
Sabina holds a Bachelor of Science in Commerce with concentrations in Management Information Systems and Finance from the University of Virginia, and a Master of Science in Management and Systems from New York University.
CloseAdam Finkelstein, Counsel, Manatt Health
With a practice focused on the intersection of managed care, federal health care programs and healthcare innovation, Adam guides health plans and other stakeholders on emerging developments and complex regulatory matters in the Medicare Advantage, Part D and Medicaid managed care programs. In addition, he is a recognized thought leader and “go to” resource on and delivery system transformation initiatives in the Medicare and Medicaid programs and innovations in insurance benefit design.
Prior to joining Manatt, Adam served in the CMS Center for Medicare and Medicaid Innovation. In that role, he launched and led the Medicare Advantage Value-Based Insurance Design model test—an innovative test of benefit flexibilities for Medicare Advantage and Medicare Part D enrollees.
Adam has also been in-house counsel for one of the country’s largest national insurers, supporting its Medicaid and CHIP business lines. He held lead legal responsibility for the company’s Medicaid managed care provider relationships, helped launch Medicare-Medicaid plans, and guided new proposals to state Medicaid agencies.
Adam serves as an appointee to the Montgomery County, MD Commission on Health.
CloseYvette Fontenot, CEO, Impact Health Policy Partners
Yvette Fontenot has nearly 25 years of Federal health care experience and has held senior positions on Capitol Hill as well as in the White House and at HHS. She is an expert on the Federal legislative and regulatory process and has long standing relationships with lawmakers, regulators, and thought-leaders. She is currently serving as the Chief Executive Officer of Impact Health Policy Partners.
CloseJudi Germano, Adjunct Professor of Law, NYU Law; Founder & Lead Counsel, GermanoLaw LLC; Distinguished Fellow, NYU Center for Cybersecurity
Judith H. Germano is a nationally-recognized thought leader on cybersecurity governance and privacy issues. She is a Distinguished Fellow at the NYU Center for Cybersecurity (CCS) and Senior Fellow at the Reiss Center on Law and Security, and an Adjunct Professor of Law at NYU School of Law and NYU Stern School of Business. Judi founded the Women Leaders in Cybersecurity series, and leads the CCS Cybersecurity Leaders Roundtable series of corporate executives and senior government officials addressing critical cybersecurity concerns. Judi is a member of the Board of Directors of Dime Community Bancshares Inc. (Nasdaq: DCOM), and serves on the Enterprise Risk, Strategic Planning and Credit Risk committees. Judi also is the founder of GermanoLaw LLC, advising public and privately-held companies and executives on enterprise risk management, cybersecurity and privacy matters, securities fraud and other complex white-collar criminal and regulatory-compliance issues. At GermanoLaw, Judi regularly counsels corporations, senior executives and boards on matters of corporate governance, federal and internal investigations, crisis management, and criminal as well as civil defense.
Judi previously was Chief of Economic Crimes at the US Attorney’s Office for the District of New Jersey. A federal prosecutor for 11 years, Judi supervised and prosecuted complex criminal cases of national and international impact, involving cybercrime, securities and other financial fraud, identity theft, corruption, export enforcement and national security. Judi handled and supervised global cybercrime investigations and prosecuted the District of New Jersey’s first criminal case arising out of evidence obtained pursuant to the Foreign Intelligence Surveillance Act (FISA). Before joining the US Attorney’s Office, Judi worked at the global law firm Shearman & Sterling, and also served as a law clerk to the Honorable Joseph M. McLaughlin of the US Court of Appeals for the Second Circuit, and the Honorable Dominic J. Squatrito of the US District Court for the District of Connecticut.
Judi has a BS from Cornell University, and a JD from St. John’s University School of Law, as a merit scholar. Judi is co-author of two books and has written various whitepapers and articles, including, among others: “Cybersecurity Partnerships: A New Era of Collaboration,” “Third-Party Risk and Corporate Responsibility,” and co-authored “After the Breach: Cybersecurity Liability Risk.”
CloseEric Gold is an accomplished health care partner and leader of Manatt’s Boston offices. Eric handles government and internal investigations, state regulatory matters, and health policy engagements. He leverages his experience in government enforcement and health care policy to advise public and private clients on complex matters involving health care access, insurance coverage, behavioral health, and other regulatory issues.
Prior to joining Manatt, Eric served as Chief of the Health Care Division at the Massachusetts Attorney General’s Office where he oversaw the Office’s health care enforcement and policy portfolio. In his prior role, Eric led civil investigations and litigation under the Massachusetts consumer protection law involving payers, providers, and pharmaceutical manufacturers. These efforts regularly had high-profile implications and included negotiations of opioid-related claims and enforcement of mental health parity laws. Eric additionally played a key role in several pieces of major litigation to prevent federal health policy rollbacks limiting Massachusetts residents’ access to coverage.
In addition to his civil enforcement and litigation experience, Eric played an important role in various policy initiatives. Eric oversaw examinations of health care cost trends and developed efforts to improve health care equity, access, and affordability throughout Massachusetts. He led the development of the first government report in the state to quantify the effect of prescription drug rebates on drug prices, and oversaw a cost trend report focused on the equity implications of risk adjusted payments in the Massachusetts individual and small group insurance markets. Eric worked collaboratively across state government and with private stakeholders to improve equitable access to affordable health care for all residents.
Close